Article Test

Home  >  Medical Research Archives  >  Issue 149  > Use of Ixolaris as a Diagnostic Tool for Cancer Models
Published in the Medical Research Archives
Jun 2022 Issue

Use of Ixolaris as a Diagnostic Tool for Cancer Models

Published on Jun 01, 2022

DOI 

Abstract

 

Ixolaris is a tick salivary protein that binds to Factor Xa or Factor X as a scaffold for inhibition of the Tissue Factor (TF)/Factor VIIa (FVIIa). TF is not normally expressed in cells that are in direct contact with blood. However, TF is abnormally expressed under several pathological conditions, including inflammation, infectious diseases and cancer. It is known for decades that TF is a risk factor for metastasis, and in mouse models, TF drives metastasis in a coagulation-dependent manner. For these reasons, TF has recently been described as a potential target that can be exploited to image aggressive tumors. Ixolaris has been succcesfully used to treat some pre-clinical cancer models. It also has been shown its’ radiolabeling for diagnostic and therapeutic purposes. The aim of this article is to show that Ixolaris could be an interesting tool to diagnose cancer, and also treat it in a near future. Some key findings presented here are that TF has recently been described as a potential target that can be exploited to image aggressive tumors, once it is often associated with migration, invasion, proliferation, metastasis, the inhibition of apoptosis and the production of several pro-aggressive factors.

Author info

Sergio Souza, Thiago Barboza, Bianca Gutfilen, Robson Monteiro

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?